Modalis Therapeutics Corporation
TSE Growth
¥36.00
-16.28%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.06.
- Current assets comfortably cover current liabilities (current ratio 21.46).
- Sales have compounded about 3,582% a year over five years.
!Watch-points
- Thin interest cover: operating profit covers interest only about -788.8 times.
- Return on equity is on the lower side at -78.6%.
- Return on capital employed is on the lower side at -78.2%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
-2.31
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap¥38億
Current Price¥ 36.00
High / Low¥ 84.00 / 29.00
Stock P/E-1.29
Book Value¥ 31.80
Dividend Yield0%
ROCE-78.17%
ROE-78.55%
Debt to Equity0.06
Current Ratio21.46
P/B Ratio1.4180486
EPS¥ -27.86
ICR-788.80
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity